Diffuse Alveolar Hemorrhage as a Complication of Intrapleural Fibrinolytic Therapy

J Bronchology Interv Pulmonol. 2017 Oct;24(4):e54-e56. doi: 10.1097/LBR.0000000000000400.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Bronchoalveolar Lavage / methods
  • Bronchoscopy / methods
  • Chest Tubes / adverse effects
  • Chest Tubes / standards
  • Deoxyribonuclease I / administration & dosage
  • Deoxyribonuclease I / adverse effects
  • Deoxyribonuclease I / therapeutic use
  • Fibrinolytic Agents / adverse effects
  • Fibrinolytic Agents / therapeutic use
  • Hemoptysis / diagnosis*
  • Hemoptysis / etiology
  • Hemorrhage / chemically induced*
  • Hemorrhage / diagnostic imaging
  • Hemorrhage / surgery
  • Humans
  • Male
  • Pulmonary Alveoli / blood supply*
  • Pulmonary Alveoli / pathology
  • Recombinant Proteins / administration & dosage
  • Recombinant Proteins / adverse effects
  • Recombinant Proteins / therapeutic use
  • Thoracic Surgery, Video-Assisted / methods
  • Thrombolytic Therapy / adverse effects*
  • Tissue Plasminogen Activator / administration & dosage
  • Tissue Plasminogen Activator / adverse effects
  • Tissue Plasminogen Activator / therapeutic use
  • Treatment Outcome

Substances

  • Fibrinolytic Agents
  • Recombinant Proteins
  • Deoxyribonuclease I
  • dornase alfa
  • Tissue Plasminogen Activator